ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $727,000 | +19.0% | 61,803 | +38.1% | 0.01% | -35.0% |
| Q1 2019 | $611,000 | +259.4% | 44,741 | +169.6% | 0.02% | +150.0% |
| Q4 2018 | $170,000 | -50.3% | 16,597 | -23.3% | 0.01% | -52.9% |
| Q2 2018 | $342,000 | -2.6% | 21,639 | -21.6% | 0.02% | -19.0% |
| Q1 2018 | $351,000 | +26.7% | 27,614 | +14.1% | 0.02% | +40.0% |
| Q4 2017 | $277,000 | -3.1% | 24,209 | +3.6% | 0.02% | -6.2% |
| Q3 2017 | $286,000 | +652.6% | 23,373 | +611.7% | 0.02% | +700.0% |
| Q2 2017 | $38,000 | -54.2% | 3,284 | -18.2% | 0.00% | -71.4% |
| Q4 2016 | $83,000 | +84.4% | 4,013 | +190.8% | 0.01% | +133.3% |
| Q3 2016 | $45,000 | +28.6% | 1,380 | -1.4% | 0.00% | +50.0% |
| Q2 2016 | $35,000 | +52.2% | 1,400 | +47.1% | 0.00% | +100.0% |
| Q1 2016 | $23,000 | -67.6% | 952 | -55.6% | 0.00% | -75.0% |
| Q4 2015 | $71,000 | -65.4% | 2,142 | -65.8% | 0.00% | -60.0% |
| Q3 2015 | $205,000 | -69.0% | 6,269 | -49.8% | 0.01% | -68.8% |
| Q2 2015 | $662,000 | +321.7% | 12,495 | +130.4% | 0.03% | +300.0% |
| Q1 2015 | $157,000 | +946.7% | 5,424 | +971.9% | 0.01% | +700.0% |
| Q4 2014 | $15,000 | – | 506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |